| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 09/21/2006 | WO2006097624A1 7-(2-(4-(3-trifluoromethyl-phenyl)-1,2,3,6-tetrahydro-pyrid-1-yl)ethyl) isoquinoline besylate salt, preparation and therapeutic use thereof |
| 09/21/2006 | WO2006097459A1 Method for preventing cardiovascular diseases |
| 09/21/2006 | WO2006097273A1 Compounds having immunomodulator activity |
| 09/21/2006 | US20060211764 Cell activator, process for producing cell activator and apparatus therefor |
| 09/21/2006 | US20060211696 IMIDAZO[1,2-b]PYRIDAZINE COMPOUND |
| 09/21/2006 | US20060211694 antiinflammatory agent for treating asthma and chronic pulmonary inflammatory disease |
| 09/21/2006 | US20060211664 Method for treating erectile dysfunction and increasing libido in men |
| 09/21/2006 | US20060211661 24 hydroxyvitamin d, analogs and uses thereof |
| 09/21/2006 | US20060211659 Novel compounds of the N-acylamino amide family, compositions comprising them and uses thereof |
| 09/21/2006 | US20060211618 Polynucleotides and polypeptides of the erythropoietin gene |
| 09/21/2006 | US20060211613 Administering parathyroid hormone and bone resorption inhibitor; bone disorders |
| 09/21/2006 | US20060211607 Somatostatin-dopamine chimeric analogs |
| 09/21/2006 | US20060211602 Use of alanyl aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 09/21/2006 | US20060211150 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211149 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211143 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211142 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211049 Estrogen related receptor, ERRalpha, a regulator of bone formation |
| 09/21/2006 | US20060210607 plant extracts from soybean, extracted in the presence of cyclodextrin ; enzymatically-modified isoflavones; easy adsorbed by the body, kept therein at a high concentration for a long time; increase the bone density and prevent osteoporosis; beverages, cosmetics, pharmaceuticals, or feeds; |
| 09/21/2006 | US20060210550 Angiogenesis inducer |
| 09/21/2006 | CA2602609A1 Novel anthranilic acid derivative or salt thereof |
| 09/21/2006 | CA2601717A1 Pyrazolopyrimidine derivative or pharmaceutically acceptable salt thereof |
| 09/21/2006 | CA2600822A1 Method for preventing cardiovascular diseases |
| 09/21/2006 | CA2599643A1 Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 09/21/2006 | CA2599637A1 7-(2-(4-(3-trifluoromethyl-phenyl)-1,2,3,6-tetrahydro-pyrid-1-yl)ethyl) isoquinoline besylate salt, preparation and therapeutic use thereof |
| 09/20/2006 | EP1702928A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2006 | EP1702924A2 Novel hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof |
| 09/20/2006 | EP1702920A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/20/2006 | EP1701933A1 Novel compounds |
| 09/20/2006 | EP1353916B1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/20/2006 | EP1292621B1 Compositions for treating autoimmune disease |
| 09/20/2006 | EP1272530B1 Clathrate complexes formed by hyaluronic acid derivatives and use thereof as pharmaceuticals |
| 09/20/2006 | EP1161944B1 Drugs, foods and oral compositions containing stilbene-type compounds |
| 09/20/2006 | EP0923582B1 Substituted 6,5-hetero-bicyclic derivatives |
| 09/20/2006 | CN1835974A Antibodies specific for sclerostin and methods for increasing bone mineralization |
| 09/20/2006 | CN1835969A Mechanism of conditional regulation of hypoxia-inducible factor-1 by von Hippel-Lindau tumor suppressor protein |
| 09/20/2006 | CN1835950A Imidazopyridine derivatives |
| 09/20/2006 | CN1835766A Osteogenesis promoter |
| 09/20/2006 | CN1835745A Omega-3 fatty acids for the treatment of canine ostheoarthritis |
| 09/20/2006 | CN1833700A Medicinal compsns. for treating rheumatism and rheumatoid arthritis and its prepn. method |
| 09/20/2006 | CN1833693A Red medicine gel for treating traumatic injury and its prepn. method |
| 09/20/2006 | CN1833680A Chinese medicinal pills for treating rheumatism and rheumatoid arthritis |
| 09/20/2006 | CN1833679A Chinese medicine for treating sprain/fall broken |
| 09/20/2006 | CN1833671A Paste for relieving mammary gland gall |
| 09/20/2006 | CN1833664A Pterigospermin capsules and prodn. method |
| 09/20/2006 | CN1275964C 7-oxo pyridopyrimidines as inhibitors of a cellular proliferation |
| 09/20/2006 | CN1275954C Hydroxamic acid derivatives |
| 09/20/2006 | CN1275917C Glucocorticoid receptor modulators |
| 09/20/2006 | CN1275641C Tetany resolving tincture |
| 09/20/2006 | CN1275636C Chinese medicine oral powder and plaster for treating rheumatism and rheumatoid disease and their prepn process |
| 09/20/2006 | CN1275631C Externally applied herbal liquor having special therapeutic effect for rheumatic arthritis |
| 09/20/2006 | CN1275625C Plaster for treating hyperosteogeny and arthralgia of winddampness |
| 09/20/2006 | CN1275606C Medical usage of simonder wood oil |
| 09/20/2006 | CN1275596C Application of probuco monoester intreating amgiocardiopathy and inflammatry disease |
| 09/19/2006 | US7109354 Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 09/19/2006 | US7109342 Antiinflammatory agents; antiallergens; autoimmune diseases |
| 09/19/2006 | US7109231 Antiinflammatory agents; sepsis |
| 09/19/2006 | US7109224 Acyl guanidine compounds and use thereof |
| 09/19/2006 | US7109219 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 09/19/2006 | US7109202 Such as 3-(2-(6-methyl-pyridin-2-ylamino)-5-(1,2,4)triazol-1-yl-thiazol-4 -yl)benzonitrile for treatment of inflammatory or obstrucive airways diseases |
| 09/19/2006 | US7109194 3-heteroaryl-3, 5-dihydro-4-oxo-4H-pyridazino[4, 5-b]indole-1-carboxamide derivatives their preparations and therapeutic use |
| 09/19/2006 | US7109191 for inhibiting bone resorption, restenosis, atherosclerosis, inflammatory arthritis, diabetic retinopathy, macular degeneration, angiogenesis, cancer |
| 09/19/2006 | US7109184 Phosphate transport inhibitors |
| 09/19/2006 | US7109181 Administering to a subject a purinergic receptor agonist in an amount therapeutically effective to alter the amount or formulation of synovial fluids |
| 09/19/2006 | US7109176 For therapy of inflammatory diseases and conditions in humans and animals |
| 09/19/2006 | US7109164 Administering compounds such as 3-[[3,5-dibromo-[4-hydroxy-3-(1-methylethyl)phenoxy]-phenyl]amino]-3-oxopropanoic acid for therapy of obesity, hypercolesterolemia atherosclerosis, depression, osteoporosis, hypothyroidism, goiter, glaucoma, cardiac arrhythmia, congestive heart failure, or a skin disorder |
| 09/19/2006 | US7108868 Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia |
| 09/19/2006 | CA2388830C Oral solution containing galanthamine and a sweetening agent |
| 09/19/2006 | CA2240845C New barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 09/19/2006 | CA2149459C Acylated aminoalkanimidazoles and -triazoles |
| 09/19/2006 | CA2083493C Association between a human immunodeficiency virus-related retrovirus and sjogren's syndrome |
| 09/14/2006 | WO2006096270A1 Pyrrolopyrimidines useful as inhibitors of protein kinase |
| 09/14/2006 | WO2006096073A1 High pressure processing of metal ion lactoferrin |
| 09/14/2006 | WO2006095906A1 Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient |
| 09/14/2006 | WO2006095268A1 Crystal forms of an imidazole derivative |
| 09/14/2006 | WO2006095150A1 Combination of a silicon containing component and a hormone |
| 09/14/2006 | WO2006012492A3 Compositions and methods for viscosupplementation |
| 09/14/2006 | US20060205796 Method for treating pain or pruritis by administering opinoid receptor agonist comprising 2-phenylbenzothiazoling derivative |
| 09/14/2006 | US20060205763 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders |
| 09/14/2006 | US20060205762 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders |
| 09/14/2006 | US20060205745 Microcrystal |
| 09/14/2006 | US20060205734 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/14/2006 | US20060205712 e.g. N-[2-[4-(2-(S)-amino-6-dimethylamino-hexanoyl)-piperazin-1-yl]-1,1-dimethyl-2-oxo-ethyl]-2,4-dichloro-3-(2-methyl -quinolin-8-yloxy-methyl)-benzensulfonamide trifluoroacetate; antiinflammatory agent; asthma, chronic bronchitis, allergic rhinitis, obstructive pulmonary disease (COPD) |
| 09/14/2006 | US20060205711 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 09/14/2006 | US20060205708 such as 4-methoxybenzaldehyde O-{2-[3-(3-ethoxy-4-methoxyphenyl)-5,6-dihydro-4H-pyridazin-1-yl]-2-oxoethyl}oxime; phosphodiesterase IV inhibitors |
| 09/14/2006 | US20060205707 adenosine triphosphate inhibitors used for the treatment of cancer; anticarcinogenic agents |
| 09/14/2006 | US20060205676 I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs; antiinflammatory, antitumor and antiischemic effects; asthma; nuclear factor kappa B inhibitors; 7-(2-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one |
| 09/14/2006 | US20060205659 Peptide radical having 5-25 amino acids with its N-terminus capped with a monoester of fumaric acid; used to treat autoimmune diseases, mitochondrial diseases, and NF-kappaB mediated diseases and in transplantation medicine |
| 09/14/2006 | US20060205655 Nucleic acids encoding (poly) peptides having CHIPS activity |
| 09/14/2006 | US20060205038 antagonist antibody that blocks binding of IL-17; degenerative cartilaginous disorders and other inflammatory diseases |
| 09/14/2006 | US20060205018 Polypeptides which have zinc metalloprotease activities and are referred to as IGS5, and polynucleotides encoding such polypeptides; use in therapy |
| 09/14/2006 | US20060204591 Treatment of mucosal membranes |
| 09/14/2006 | CA2600460A1 High pressure processing of metal ion lactoferrin |
| 09/14/2006 | CA2600035A1 Combination of a silicon containing component and a hormone |
| 09/14/2006 | CA2599879A1 Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient |
| 09/14/2006 | CA2596830A1 Pyrrolopyrimidines useful as inhibitors of protein kinase |
| 09/13/2006 | EP1700921A2 Regulation of a human asparagine-hydroxylase |
| 09/13/2006 | EP1700867A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/13/2006 | EP1700603A2 Immunostimulatory nucleic acids |
| 09/13/2006 | EP1699823A2 Use of il-18 binding protein in inflammations |